Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net income (loss) $ 81,920 $ 41,798 $ 31,035
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for loss on receivables 8,027 0 0
Depreciation and amortization 3,593 4,526 3,550
Amortization of deferred financing costs 6,435 10,727 9,621
Equity-based compensation 14,160 10,066 11,304
Equity method investments (34,392) 4,312 (7,746)
Non-cash gain on securitization (56,717) (25,728) (28,915)
Gain on sale of receivables and investments 13,241 0 2,137
Changes in receivables held-for-sale 0 12,685 (3,338)
Loss on debt extinguishment 0 9,245 0
Changes in accounts payable and accrued expenses 5,184 6,882 (327)
Other (11,962) (15,720) (5,604)
Net cash provided by operating activities 29,489 58,793 11,717
Cash flows from investing activities      
Equity method investments (152,096) (76,349) (232,811)
Equity method investment distributions received 71,183 88,160 75,114
Proceeds from sales of equity method investments 81,297 35,849 6,044
Purchases of and investments in receivables (497,866) (292,834) (111,161)
Principal collections from receivables 57,670 345,956 98,482
Proceeds from sales of receivables 134,932 0 78,857
Purchases of real estate 0 (27,549) (170,982)
Purchases of investments (45,830) (25,308) (22,115)
Principal collections from investments 6,626 5,252 3,733
Proceeds from sales of investments and securitization assets 139,230 0 0
Funding of escrow accounts (28,953) (34,980) (37,613)
Withdrawal from escrow accounts 30,707 33,108 15,986
Other 1,959 (505) (1,414)
Net cash provided by (used in) investing activities (201,141) 50,800 (297,880)
Cash flows from financing activities      
Proceeds from credit facilities 101,500 171,783 302,612
Principal payments on credit facilities (328,465) (46,604) (515,777)
Proceeds from issuance of non-recourse debt 130,988 69,255 609,332
Principal payments on non-recourse debt (206,705) (390,537) (79,459)
Proceeds from issuance of senior unsecured notes 507,313 0 0
Proceeds from issuance of convertible notes 0 0 150,000
Payments on deferred funding obligations (18,791) (73,946) (124,785)
Net proceeds of common stock issuances 138,383 187,265 96,899
Payments of dividends and distributions (86,406) (70,989) (68,234)
Other (18,932) (14,644) (25,392)
Net cash provided by (used in) financing activities 218,885 (168,417) 345,196
Increase (decrease) in cash, cash equivalents, and restricted cash 47,233 (58,824) 59,033
Cash, cash equivalents, and restricted cash at beginning of period 59,353 118,177 59,144
Cash, cash equivalents, and restricted cash at end of period 106,586 59,353 118,177
Interest paid 48,056 72,078 48,865
Non-cash changes in deferred funding obligations and non-recourse debt (financing activity) (112,027) (6,973) 101,324
Non-cash changes in receivables and investments (investing activity) 93,730 (248) (85,933)
Non-cash changes in residual assets (investing activity) $ (61,001) $ (25,827) $ (28,777)